{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:03:13Z","timestamp":1788346993238,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiologic Clinics of North America"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.rcl.2013.05.006","type":"journal-article","created":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T05:30:20Z","timestamp":1374039020000},"page":"895-911","source":"Crossref","is-referenced-by-count":22,"title":["PET\/CT in Gynecologic Malignancies"],"prefix":"10.1016","volume":"51","author":[{"given":"Jacqueline","family":"Brunetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcl.2013.05.006_bib1","series-title":"Clinical gynecologic oncology","first-page":"313","article-title":"Epithelial ovarian cancer","author":"Copeland","year":"2007"},{"key":"10.1016\/j.rcl.2013.05.006_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer\u2013a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rcl.2013.05.006_bib3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/IGC.0b013e318251c8e3","article-title":"An overview of current diagnosis and treatment in ovarian cancer","volume":"22","author":"Mould","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.rcl.2013.05.006_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/gyno.2000.5910","article-title":"Expression of GLUT-1 transporter in borderline and malignant epithelial tumors of the ovary","volume":"79","author":"Cantuaria","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rcl.2013.05.006_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2010.11.019","article-title":"Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction","volume":"121","author":"Semaan","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rcl.2013.05.006_bib6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/1097-0142(20010901)92:5<1144::AID-CNCR1432>3.0.CO;2-T","article-title":"GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy","volume":"92","author":"Cantuaria","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.rcl.2013.05.006_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/0284186X.2010.500296","article-title":"Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer","volume":"50","author":"Risum","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.rcl.2013.05.006_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1148\/radiol.2233001850","article-title":"Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings","volume":"223","author":"Fenchel","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.rcl.2013.05.006_bib9","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/IGC.0b013e3181bf82f3","article-title":"Laparoscopy staging of early ovarian cancer our experience and review of the literature","volume":"19","author":"Ghezzi","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.rcl.2013.05.006_bib10","first-page":"117","article-title":"Laparoscopic surgical staging of early ovarian cancer","volume":"4","author":"Weber","year":"2011","journal-title":"Rev Obstet Gynecol"},{"key":"10.1016\/j.rcl.2013.05.006_bib11","first-page":"31","article-title":"Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study","volume":"12","author":"Rutten","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.rcl.2013.05.006_bib12","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.ejrad.2010.07.013","article-title":"FDG PET\/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy","volume":"80","author":"De Iaco","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.rcl.2013.05.006_bib13","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.ygyno.2009.10.059","article-title":"Diagnosis and staging of primary ovarian cancer: correlation between PET\/CT, Doppler UD, and CT or MRI","volume":"116","author":"Nam","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rcl.2013.05.006_bib14","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ejrad.2011.01.112","article-title":"Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patient with ovarian cancer: a meta-analysis","volume":"81","author":"Yuan","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.rcl.2013.05.006_bib15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00259-011-1984-9","article-title":"Prognostic significance of mediastinal 18F-FDG uptake in PET\/CT in advanced ovarian cancer","volume":"39","author":"Bats","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 8","key":"10.1016\/j.rcl.2013.05.006_bib16","doi-asserted-by":"crossref","first-page":"viii40","DOI":"10.1093\/annonc\/mdr470","article-title":"Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up","volume":"22","author":"Pignata","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rcl.2013.05.006_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11912-011-0199-3","article-title":"Recurrent ovarian cancer: when and how to treat","volume":"13","author":"Hall","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.rcl.2013.05.006_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/IGC.0b013e31821bb88c","article-title":"Considering early detection of relapsed ovarian cancer: review of the literature","volume":"21","author":"Geurts","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.rcl.2013.05.006_bib19","first-page":"CR84","article-title":"Tumor marker CA-125 as an evaluator and response indicator in ovarian cancer: its quantitative correlation with tumor volume","volume":"11","author":"Kumar","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.rcl.2013.05.006_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0090-8258(90)90076-W","article-title":"Does serum CA-125 level prior to second-look laparotomy for invasive ovarian carcinoma predict size of residual disease?","volume":"38","author":"Patsner","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rcl.2013.05.006_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0090-8258(89)90550-7","article-title":"Use of CA 125 to monitor patients with ovarian epithelial carcinomas","volume":"33","author":"Podczaski","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rcl.2013.05.006_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0090-8258(89)90008-5","article-title":"Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma","volume":"35","author":"Meier","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rcl.2013.05.006_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00404-010-1404-6","article-title":"Combined positron emission tomography and tumor markers for detecting ovarian cancer","volume":"283","author":"Pan","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.rcl.2013.05.006_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/cbr.2010.0872","article-title":"Early detection of\u00a0recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by 2-[F-18]fluoro-2-deoxy-D-glucose-positron emission tomography\/computed tomography","volume":"26","author":"Peng","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.rcl.2013.05.006_bib25","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/IGC.0b013e3181e82a7f","article-title":"Clinical utility of positron emission tomography\/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels","volume":"20","author":"Bhosale","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.rcl.2013.05.006_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11307-010-0468-9","article-title":"Value of FDG PET\/CT in patients with treated ovarian cancer and raised CA125 serum levels","volume":"14","author":"Palomar","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.rcl.2013.05.006_bib27","first-page":"3","article-title":"The role of FDG-PET\/CT in ovarian cancer patients with high tumor markers or suspicious lesions on contrast-enhanced CT in evaluation of recurrence and\/or in determination of intraabdominal metastases","volume":"31","author":"Sari","year":"2012","journal-title":"Rev Esp Med Nucl"},{"issue":"Suppl 1","key":"10.1016\/j.rcl.2013.05.006_bib28","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/1472-6874-4-S1-S13","article-title":"Cancer of the uterine cervix","volume":"4","author":"Duarte-Franco","year":"2004","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.rcl.2013.05.006_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4161\/cbt.11.3.14686","article-title":"Molecular pathogenesis of cervical cancer","volume":"11","author":"Ibeanu","year":"2011","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"10.1016\/j.rcl.2013.05.006_bib30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0090-8258(03)00402-5","article-title":"Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix","volume":"90","author":"Tran","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib31","first-page":"33","article-title":"Supraclavicular lymph node metastases in cervical cancer","volume":"28","author":"Qiu","year":"2007","journal-title":"Eur J Gynaecol Oncol"},{"issue":"6","key":"10.1016\/j.rcl.2013.05.006_bib32","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1349-7006.2010.01532.x","article-title":"Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography\/computed tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis","volume":"101","author":"Choi","year":"2010","journal-title":"Cancer Sci"},{"issue":"9","key":"10.1016\/j.rcl.2013.05.006_bib33","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/cncr.25739","article-title":"Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation with surgical findings with positron emission tomography\/computed tomography findings","volume":"117","author":"Ramirez","year":"2011","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.rcl.2013.05.006_bib34","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1245\/s10434-011-1583-9","article-title":"Accuracy of 19-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with locally advanced cervical carcinoma","volume":"18","author":"Leblanc","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000162101","article-title":"Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before hysterectomy","volume":"67","author":"Chung","year":"2009","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"10.1016\/j.rcl.2013.05.006_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cncr.26317","article-title":"Can radicality of surgery be safely modulated on the basis of MRI and PET\/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?","volume":"118","author":"Ferrandina","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.rcl.2013.05.006_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2011.07.096","article-title":"Preoperative staging of cervical cancer: is 18-FDG-PET\/CT really effective in patients with early stage disease?","volume":"123","author":"Signorelli","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"19","key":"10.1016\/j.rcl.2013.05.006_bib38","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2003.01.102","article-title":"Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer","volume":"21","author":"Yen","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1200\/JCO.1999.17.1.41","article-title":"Positron emission tomography for evaluating para-aortic nodal metastases in locally advanced cervical cancer before surgical staging: a surgicopathologic study","volume":"17","author":"Rose","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.rcl.2013.05.006_bib40","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/cncr.21527","article-title":"Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography","volume":"104","author":"Wright","year":"2005","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib41","first-page":"22","article-title":"18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression","volume":"45","author":"Tzu-Chen","year":"2004","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.rcl.2013.05.006_bib42","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1525-1438.2007.00902.x","article-title":"The prognostic value of pre-treatment 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography scan in women with cervical cancer","volume":"17","author":"Unger","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.rcl.2013.05.006_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1102\/1470-7330.2008.0022","article-title":"The prognostic value of PET and PET\/CT in cervical cancer","volume":"8","author":"Grigsby","year":"2008","journal-title":"Cancer Imaging"},{"issue":"8","key":"10.1016\/j.rcl.2013.05.006_bib44","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-010-1413-5","article-title":"Preoperative [18F]FDG PET\/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer","volume":"37","author":"Chung","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.rcl.2013.05.006_bib45","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00259-009-1336-1","article-title":"(18)F-FDG PET in stage IB\/IIB cervical adenocarcinoma\/adenosquamous carcinoma","volume":"37","author":"Chou","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.rcl.2013.05.006_bib46","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/cncr.24972","article-title":"Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer","volume":"116","author":"Kidd","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.rcl.2013.05.006_bib47","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ijrobp.2009.11.031","article-title":"Pelvic lymph node status assessed by 18F-fluorodeoxyglucose positron emission tomography predicts low-risk group for distant recurrence in locally advanced cervical cancer: a prospective study","volume":"70","author":"Kang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.rcl.2013.05.006_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00432-011-1092-z","article-title":"The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer","volume":"138","author":"Pan","year":"2012","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ygyno.2012.06.027","article-title":"FDG-PET-based\u00a0prognostic nomograms for locally advanced cervical cancer","volume":"127","author":"Kidd","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.rcl.2013.05.006_bib50","first-page":"437","article-title":"The impact of 18FDG in radiotherapy treatment planning and in prediction in patients with cervix carcinoma: results of pilot study","volume":"55","author":"Dolezelova","year":"2008","journal-title":"Neoplasma"},{"issue":"4","key":"10.1016\/j.rcl.2013.05.006_bib51","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ijrobp.2008.02.063","article-title":"Prospective clinical trial of positron emission tomography\/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes","volume":"72","author":"Esthappan","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0360-3016(02)03804-X","article-title":"PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes\u2013a dose-escalation treatment planning study","volume":"55","author":"Mutic","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.rcl.2013.05.006_bib53","first-page":"533","article-title":"PET\/CT and radiotherapy in gynecologic malignancy","volume":"54","author":"Caroli","year":"2010","journal-title":"Q\u00a0J Nucl Med Mol Imaging"},{"key":"10.1016\/j.rcl.2013.05.006_bib54","unstructured":"National Comprehensive Cancer Institute Guidelines. Version 2012 MS-7."},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0090-8258(03)00256-7","article-title":"The role of PET scanning in detection of recurrent cervical cancer","volume":"90","author":"Havrilesky","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ygyno.2006.02.016","article-title":"Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis","volume":"103","author":"Chung","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.rcl.2013.05.006_bib57","first-page":"227","article-title":"F18-FDG-PET\/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical cancer","volume":"63","author":"Cetina","year":"2011","journal-title":"Rev Invest Clin"},{"issue":"4","key":"10.1016\/j.rcl.2013.05.006_bib58","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0360-3016(02)04287-6","article-title":"Posttherapy surveillance of cervical cancer by FDG-PET","volume":"55","author":"Grigsby","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1016\/j.rcl.2013.05.006_bib59","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1002\/cncr.25991","article-title":"Impact of post-therapy emission tomography on prognostic stratification and surveillance after chemoradiation for cervical cancer","volume":"117","author":"Siva","year":"2011","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.rcl.2013.05.006_bib60","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1016\/j.ejrad.2012.02.015","article-title":"Predictive role of post-treatment [(18)F]FDG PET\/CT in patients with uterine cervical cancer","volume":"81","author":"Hoon","year":"2012","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2011.10.009","article-title":"The epidemiology of endometrial and ovarian cancer","volume":"26","author":"Cramer","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1028-4559(08)60102-3","article-title":"Molecular carcinogenesis of endometrial cancer","volume":"46","author":"Liu","year":"2007","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.rcl.2013.05.006_bib63","first-page":"228","article-title":"A\u00a0dualistic model for endometrial carcinogenesis based on immunohistochemical molecular genetic analysis","volume":"81","author":"Lax","year":"1997","journal-title":"Verh Dtsch Ges Pathol"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/AOG.0b013e3181e3e7e8","article-title":"Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis","volume":"116","author":"Timmermans","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.rcl.2013.05.006_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.maturitas.2010.11.010","article-title":"Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach","volume":"68","author":"van Hanegem","year":"2011","journal-title":"Maturitas"},{"issue":"11","key":"10.1016\/j.rcl.2013.05.006_bib66","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.ejrad.2012.01.024","article-title":"18F-FDG PET or PET-CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis","volume":"81","author":"Chang","year":"2012","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.rcl.2013.05.006_bib67","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s12149-011-0496-9","article-title":"Preoperative nodal staging of uterine cancer: is contrast-enhanced PET\/CT more accurate than non-enhanced PET\/CT or enhanced CT alone?","volume":"25","author":"Kitajima","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.rcl.2013.05.006_bib68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12149-011-0474-2","article-title":"Clinical value of FDG-PET for preoperative evaluation of endometrial cancer","volume":"25","author":"Suga","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"6","key":"10.1016\/j.rcl.2013.05.006_bib69","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MNM.0b013e328337cb47","article-title":"High-grade endometrial cancer: value of [(18)F] FDG PET\/CT in preoperative staging","volume":"31","author":"Picchio","year":"2010","journal-title":"Nucl Med Commun"},{"issue":"5","key":"10.1016\/j.rcl.2013.05.006_bib70","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00259-011-2057-9","article-title":"Prognostic significance of SUVmax (maximum standardized uptake value) measured by [(18)F] FDG PET\/CT in endometrial cancer","volume":"39","author":"Kitajima","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2011.06.026","article-title":"The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer","volume":"123","author":"Nakamura","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.rcl.2013.05.006_bib72","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3413\/nukmed-0375-10-12","article-title":"Preoperative risk stratification using (18)F-FDG PET\/CT in women with endometrial cancer","volume":"50","author":"Lee","year":"2011","journal-title":"Nuklearmedizin"},{"issue":"6","key":"10.1016\/j.rcl.2013.05.006_bib73","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/IGC.0b013e31821872f4","article-title":"Defining prognostic variables in recurrent endometriod endometrial cancer: a 15-year single-institution review","volume":"21","author":"Esselen","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/gyno.1995.1262","article-title":"Postsurgical surveillance of patients with FIGO stage I\/II endometrial adenocarcinoma","volume":"59","author":"Berchuck","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rcl.2013.05.006_bib75","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00259-002-0878-2","article-title":"Usefulness of 18F-FDG PET in the post-therapy surveillance of endometrial carcinoma","volume":"29","author":"Belhocine","year":"2002","journal-title":"Eur J Nucl Med"},{"issue":"3","key":"10.1016\/j.rcl.2013.05.006_bib76","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02990022","article-title":"Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer","volume":"17","author":"Saga","year":"2003","journal-title":"Ann Nucl Med"},{"issue":"4","key":"10.1016\/j.rcl.2013.05.006_bib77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00259-006-0251-y","article-title":"Post-therapy surveillance of patients with uterine cancer: value of integrated FDG PET\/CT in the detection of recurrence","volume":"34","author":"Sironi","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.rcl.2013.05.006_bib78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12149-007-0087-y","article-title":"Performance of FDG-PET\/CT in the diagnosis of recurrent endometrial cancer","volume":"22","author":"Kitajima","year":"2008","journal-title":"Ann Nucl Med"},{"issue":"7","key":"10.1016\/j.rcl.2013.05.006_bib79","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3346\/jkms.2010.25.7.1029","article-title":"Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease","volume":"25","author":"Ryu","year":"2010","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.rcl.2013.05.006_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MNM.0b013e32834e41a6","article-title":"Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging","volume":"33","author":"Sharma","year":"2012","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.rcl.2013.05.006_bib81","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00259-010-1614-y","article-title":"Post-treatment\u00a0[18F] FDG maximum uptake value as a prognostic marker of recurrence in endometrial carcinoma","volume":"38","author":"Chung","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Radiologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003383891300095X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003383891300095X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T12:17:37Z","timestamp":1646137057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003383891300095X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S003383891300095X"],"URL":"https:\/\/doi.org\/10.1016\/j.rcl.2013.05.006","relation":{},"ISSN":["0033-8389"],"issn-type":[{"value":"0033-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}